Pathogenic bacteria especially when they become dominant = pathobionts (10)
To date, approximately 1400 species of human pathogens have been identified, including viruses, bacteria, fungi, protozoa, and helminths. As the Earth Microbiome Project advances, this number is expected to raise dramatically (4). These pathogens cause 16 million deaths each year, and this situation is predicted to worsen in the future (5). Pathogenic bacteria are overrepresented in the microbial databases (11)
Pathogens comprised of viruses, bacteria, gut microbiome, and Parasites / Parasitism are a leading cause of ever-emerging diseases in humans (12)
Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa are part of the World Health Organization's Priority 1 group of pathogens. These bacteria are acknowledged as significant contributors to mortality associated with antimicrobial resistance (AMR) (13)
Bacterial metabolism is crucial for both the virulence and the survival of pathogens within a host. Furthermore, these pathogens have developed advanced metabolic strategies to manipulate host immune responses, thereby promoting infection (6)
The success of bacterial pathogens relies on sophisticated strategies for scavenging nutrients from their hosts (“nutritional virulence factors’’). Other pathogens compete effectively with the host for nutrients that are available as a result of normal host physiology (14)
Intracellular bacterial pathogens have developed ways to survive and multiply inside the host. They adjust their metabolism to cope with immune responses, environmental changes, and drugs.
Pathogens undergo significant genetic adaptations when associated with the host (15)
The presence of strain-specific variations complicates the development of effective therapies. Dominant lineages of pathogens often possess unique virulence profiles, influenced by mobile genetic elements such as pathogenicity islands and phages. These elements facilitate horizontal gene transfer, leading to the evolution of hypervirulent clones, such as methicillin-resistant Staphylococcus aureus (MRSA) (7)
Metabolites from pathogenic bacteria can signal between bacteria and hosts. This communication can enhance virulence. It helps in biofilm formation and activating virulence traits (16, 17, 18).
Although the gut microbiome is generally symbiotic or commensal, some microbiome members become pathogenic under certain circumstances (10)
Bacteria such as Escherichia coli, Fusobacterium nucleatum, and Helicobacter pylori can cause pathogenic reactions in the host (19)
Enteric pathogens, including a diverse plethora of enteric viruses, cause acute and chronic diseases (20)
Pathogenic bacteria have evolved diverse mechanisms to counteract cell-autonomous immunity, which otherwise guards both immune and non-immune cells from the onset of an infection (21, 22)
Pathogen-associated molecular patterns (PAMPs), which are motifs such as bacterial LPS and viral nucleic acid features (23)
Most pathogenic bacteria exhibit remarkable metabolic flexibility, allowing them to adapt to various niches within their hosts and exploit available nutrients effectively (24). Pathogenic bacteria release metabolites to outcompete others (25, 26)
For example, some intracellular pathogens hijack autophagic or proteolytic cellular machinery to release amino acids that can be exploited as carbon and energy sources (27, 28)
There are also pathogenic species (Bad Guys (certain harmful bacteria)) such as Campylobacter jejuni, Salmonella enterica, Bacteroides fragilis, Vibrio cholera, and Escherichia coli, but in a low abundance (0.1% or less) (29)
Clostridia have the potential for harmful pathogenic effects. Indigenous pathobionts are e.g. Clostridium difficile and vancomycin-resistant enterococci (30)
Pathogens impact health either directly by invading the host or by eliciting an acute inflammatory immune response (12).
Many foodborne bacterial pathogens, including the non-typhoidal serovars of Salmonella enterica (Salmonella ), directly or indirectly induce mammalian cell death (31)
This paradigm of inflammatory immune responses is even more consequential in people who may be immunocompromised (12)
But of the domain Bacteria the bacteroidetes (phylum), Alfaproteobacteria (class), Betaproteobacteria (class), gammaproteobacteria (class), deltaproteobacteria (class), chlamydiae (phylum), Spirochaetes / Spirochaetota (phylum), clostridia (class), bacilli (class) and actinobacteria (phylum) in which known human pathogens exist (32)
Pathogenic bacteria use lectins to cause disease. Lectins bind to sugars on host cells. These sugars include cell-surface receptors, N- and O-linked glycans, glycolipids, and glycosaminoglycans (1, 2)
Some bacteria target histo-blood group antigens, such as A, B, and H blood-group antigens and Lewis antigens. As a result, people who carry these antigens may be more vulnerable to infection (1, 2)
These interactions help bacteria recognize and attach to tissues. They also help bacteria avoid the immune system, form biofilms, remain in the body, and damage host cells (3).
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26)
(27)
(28)
(29)
(30)
(31)
(32)
see also:
Acinetobacter baumannii
Antibiotic resistance
Bacteria & Carcinogenesis / Oncogenesis / Tumorigenesis
Bacterial Biofilm / Microbial Biofilm (BF)
Bacterial cellular morphologies
Bacterial Sensing / Quorum Sensing (QS) system
Bad Guys (certain harmful bacteria)
Enteric pathogens
Exometabolome
Glutathione
Opportunistic infections